Publications by authors named "Jennifer Pulley"

Claim this Profile
E
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, Millie Long, Matthieu Allez, Jennifer Pulley

Lancet Gastroenterol Hepatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Severine Vermeire, Peter L Lakatos, Timothy Ritter, Stephen Hanauer, Brian Bressler, Jennifer Pulley

Lancet Gastroenterol Hepatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Biomarkers of Inflammation and Endothelial Activation in Diabetic Retinopathy.
Federica Storti, Jennifer Pulley, Pascal Kuner, Markus Abt, Ulrich F O Luhmann

Transl Vis Sci Technol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open-Label Tolerability and Actual-Use Human Factors Study of Etrolizumab Autoinjector in Healthy Volunteers.
Helen Tyrrell, Renato Ravanello, Jennifer Pulley, Meina Tao Tang, Wenhui Zhang

Adv Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers.
Wenhui Zhang, Helen Tyrrell, Han Ting Ding, Jennifer Pulley, Audrey Boruvka

Adv Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis.
Cem Gabay, Iain B McInnes, Arthur Kavanaugh, Katie Tuckwell, Micki Klearman, Jennifer Pulley

Ann Rheum Dis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab.
Andrea Rubbert-Roth, Anthony Sebba, Laura Brockwell, Ariella Kelman, Benjamin Porter-Brown, Jennifer Pulley

RMD Open· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis